Australia markets closed

Sichuan Hebang Biotechnology Corporation Limited (603077.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
2.1300-0.0200 (-0.93%)
As of 02:43PM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,428,901
8,824,108
13,038,948
9,987,354
5,260,766
Cost of revenue
6,799,215
6,771,570
7,451,315
5,854,727
4,271,965
Gross profit
1,629,686
2,052,538
5,587,633
4,132,627
988,801
Operating expenses
Research development
46,585
47,347
67,934
33,313
39,677
Selling general and administrative
155,772
152,860
126,008
117,737
145,888
Total operating expenses
567,762
569,068
1,047,699
486,116
457,936
Operating income or loss
1,061,925
1,483,470
4,539,933
3,646,511
530,864
Interest expense
26,373
24,373
51,435
77,819
82,162
Income before tax
1,102,990
1,535,966
4,478,562
3,578,380
15,809
Income tax expense
178,608
257,266
668,323
551,879
12,900
Income from continuing operations
924,382
1,278,699
3,810,239
3,026,502
2,910
Net income
916,475
1,283,244
3,806,809
3,018,471
40,942
Net income available to common shareholders
916,475
1,283,244
3,806,809
3,018,471
40,942
Basic EPS
0.16
0.15
0.44
0.36
0.00
Diluted EPS
0.16
0.15
0.44
0.36
0.00
Basic average shares
8,724,660
8,705,861
8,697,302
8,436,195
8,529,678
Diluted average shares
8,724,660
8,705,861
8,697,302
8,436,195
8,529,678